Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) traded up 50% during trading on Thursday . The stock traded as high as C$0.11 and last traded at C$0.11. 1,942,446 shares were traded during mid-day trading, an increase of 1,795% from the average session volume of 102,479 shares. The stock had previously closed at C$0.07.
Voyageur Pharmaceuticals Stock Performance
The stock has a market cap of C$13.95 million, a price-to-earnings ratio of -10.00 and a beta of 0.32. The stock’s 50 day moving average is C$0.07 and its two-hundred day moving average is C$0.06. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- 3 Warren Buffett Stocks to Buy Now
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- What is the NASDAQ Stock Exchange?
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- How to Invest in the FAANG Stocks
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
